MGNX
Macrogenics
Stock NASDAQ – Stock Market Prices, News & Analysis
MacroGenics développe des anticorps monoclonaux pour le traitement des maladies cancéreuses et auto-immunes.
$ 3.43
45.34 %
Macrogenics
$
3.43
45.34 %
MGNX
MacroGenics développe des anticorps monoclonaux pour le traitement des maladies cancéreuses et auto-immunes.
Price history of Macrogenics
Price history of Macrogenics
Performance & Momentum
6 Months
21.59 %
1 Year
11.57 %
3 Years
62.39 %
5 Years
91.77 %
Momentum
79
Similar stocks to Macrogenics
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
